Utilizing cutting-edge technologies and the latest advancements in anti-aging care, we offer a wide range of customized treatments to address your individual needs and goals
PI3K/Akt/mTOR and MAPK/ERK Pathway Activation In research settings, IGF-1 LR3 activates the PI3K/Akt pathway (involved in survival, glucose metabolism, and protein synthesis), the RAS/MAPK pathway (regulating growth and differentiation), the mTOR pathway (governing anabolic protein synthesis signalling), and IRS-1/2 cross-talk with insulin receptor signalling the full complement of IGF-1R-mediated downstream effects
Presented for research literature review only O'Neil PM et al
Your body is adapting, not failing
Clinical studies have shown that semaglutide can lead to significant reductions in body mass, with many participants experiencing a decrease of 10% to 20% of their body mass